|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
1991
|
|
gptkbp:ATCCode
|
gptkb:A04AA01
|
|
gptkbp:availableOn
|
gptkb:brand
generic
|
|
gptkbp:contraindication
|
hypersensitivity to ondansetron
|
|
gptkbp:drugClass
|
antiemetic
|
|
gptkbp:eliminationHalfLife
|
3-6 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:form
|
gptkb:tablet
solution for injection
oral disintegrating tablet
|
|
gptkbp:genericName
|
gptkb:ondansetron
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zofran
|
|
gptkbp:indication
|
chemotherapy-induced nausea and vomiting
postoperative nausea and vomiting
radiotherapy-induced nausea and vomiting
|
|
gptkbp:interactsWith
|
other serotonergic drugs
apomorphine
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
GlaxoSmithKline
|
|
gptkbp:mechanismOfAction
|
serotonin 5-HT3 receptor antagonist
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:riskFactor
|
gptkb:serotonin_syndrome
QT prolongation
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
constipation
dizziness
fatigue
headache
|
|
gptkbp:usedFor
|
nausea
vomiting
|
|
gptkbp:bfsParent
|
gptkb:Novartis
|
|
gptkbp:bfsLayer
|
4
|